Stock CLSD CLEARSIDE BIOMEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Clearside Biomedical, Inc.

Equities

CLSD

US1850631045

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
1.28 USD +4.07% Intraday chart for Clearside Biomedical, Inc. 0.00% +9.40%
05-13 HC Wainwright Adjusts Price Target on Clearside Biomedical to $5 From $6, Keeps Buy Rating MT
05-09 Transcript : Clearside Biomedical, Inc., Q1 2024 Earnings Call, May 09, 2024
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CLEARSIDE BIOMEDICAL, INC. Stock Clearside Biomedical, Inc.
 95.66M - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.24B -
ARGENX SE Stock argenx SE
 21.25B -
GENMAB A/S Stock Genmab A/S
 18.97B
  1. Stock Market
  2. Equities
  3. CLSD Stock
  4. Charts Clearside Biomedical, Inc.
  5. Sector Chart